Klf6 and Tgfb1 are upregulated during the progression of rat models of NASH (37), and hepatocyte-specific Klf6 deletion is protective against HFD-induced liver steatosis and insulin resistance, which suggests KLF6 contributes to NASH development (38). Here, KLF6 is linked to metabolic dysfunction-associated steatohepatitis.